Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk.
about
Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GNComplement cascade and kidney transplantation: The rediscovery of an ancient enemyDe novo membranoproliferative glomerulonephritis III in a renal transplant patient: case report and review of the literatureTranslational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.Dense deposit disease: clinicopathologic study of 32 pediatric and adult patientsUse of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.Complement involvement in kidney diseases: From physiopathology to therapeutical targetingClinical features and outcomes of 98 children and adults with dense deposit disease.Recurrent glomerulonephritis after kidney transplantation.Recurrent glomerulonephritis after renal transplantation: an unsolved problemProbability, predictors, and prognosis of posttransplantation glomerulonephritisDense deposit disease and C3 glomerulopathyC3 glomerulopathy: consensus report.C3 glomerulopathy: clinicopathologic features and predictors of outcome.Complement related kidney diseases: Recurrence after transplantation.Histopathology of MPGN and C3 glomerulopathies.Primary disease recurrence—effects on paediatric renal transplantation outcomes.Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies.Current status of pediatric renal transplant pathology.Understanding the complement-mediated glomerular diseases: focus on membranoproliferative glomerulonephritis and C3 glomerulopathies.Mycophenolate mofetil as a possible therapeutic option for idiopathic membranoproliferative glomerulonephritis.Case Report of Spontaneous Remission of Biopsy-Proven Idiopathic Immune Complex-Mediated Membranoproliferative Glomerulonephritis.C3 nephritic factor associated with C3 glomerulopathy in children.Kidney transplant outcomes in familial C3 glomerulopathy.Reanalysis of membranoproliferative glomerulonephritis patients according to the new classification: a multicenter study.Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis.Selection of Patients for Initial Clinical Trials of Solid Organ Xenotransplantation.Long-term outcomes of kidney transplant recipients with end-stage kidney disease attributed to presumed/advanced glomerulonephritis or unknown cause.Complement-mediated renal diseases after kidney transplantation - current diagnostic and therapeutic options in and recurrent diseases
P2860
Q26741542-C6A6B381-B463-48B2-9C9D-4B6F2BB49D03Q26829790-B3BBACC8-A9A8-4D0D-AB73-7128F80707C5Q26860761-2E013D74-D60F-41BF-9BA0-93B8D2E08F73Q33377727-BDDD1C86-B398-48EC-BD1A-C8E666AD2AD5Q33381183-952C41E9-6786-43D5-94FD-4B200D4B0713Q33403607-564EA626-EDE0-44F5-9875-C804F48D52E1Q35567841-67950362-5360-40EF-93D9-59C8BE7F2482Q35580577-44426EC9-14D0-4368-AF30-5F3FD8F27715Q36580726-5C8C6C9A-EE74-416B-9AD1-EF8828DA8395Q37084056-E55544A9-03DA-47FC-B5CD-4A1723B639F4Q37146427-005A4406-1D86-49A5-8221-AF2803223F7AQ37286653-67CE6939-6882-4DAF-81F6-95A1DE8D8C01Q37348685-795C3B00-D426-4BA7-80A5-3350E571F4B5Q37426966-A49AA155-2617-462A-83F2-91634EBB3D36Q37522557-1666EB35-1CAC-4F01-8307-6E7209B8B460Q38275117-66FF6609-7E55-4816-AFA2-341696B9C91BQ38445275-7C23F119-3A8D-4A19-9BDD-FCEC66089E11Q38749694-9DB340EE-EAE2-4C22-911E-F945740AEFEEQ38843499-91F56D5D-0BD1-4347-B1EB-B2010EE7ECD3Q38880897-D960D1E5-4214-4984-83A6-BC1A6E2E3E38Q41087203-3D436F1E-032B-435A-82BA-E8BAE13F6145Q41485811-9023BBD8-3C42-4D9B-A538-9BC010A62E36Q42246527-3AB6CD64-E6A7-4D9D-9C05-2D01DE1E5334Q42749819-63FD86D3-F86D-4D8C-A9CF-3FAB08518568Q43086742-AF0D0ADC-D83B-4FD2-BB73-78394A550A5AQ44886223-F4F00AB5-72C4-4A57-BE2F-005E2D8145D3Q51033762-724EFA51-6BC3-4D4C-9449-FBD1CBD71799Q55240851-A838845B-94D5-4E9C-B3D5-EF43EEEB536FQ58120548-BA7CEF36-4968-4B38-9170-3BAD36F12119
P2860
Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Severity of primary MPGN, rath ...... ansplantation recurrence risk.
@en
Severity of primary MPGN, rath ...... ansplantation recurrence risk.
@nl
type
label
Severity of primary MPGN, rath ...... ansplantation recurrence risk.
@en
Severity of primary MPGN, rath ...... ansplantation recurrence risk.
@nl
prefLabel
Severity of primary MPGN, rath ...... ansplantation recurrence risk.
@en
Severity of primary MPGN, rath ...... ansplantation recurrence risk.
@nl
P2093
P356
P1433
P1476
Severity of primary MPGN, rath ...... ansplantation recurrence risk.
@en
P2093
P2888
P304
P356
10.1038/SJ.KI.5000084
P407
P577
2006-02-01T00:00:00Z